臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ann lii cheng"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 176-200 / 690 (共28页)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-01T02:02:12Z	Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin	Lin C.-H.; Kuo K.-T.; Chuang S.-S.; Kuo S.-H.; Chang J.H.; Chang K.-C.; Hsu H.-C.; Tien H.-F.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:12Z	Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa	Lu Y.-S.; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:12Z	A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus	Pei Y.Y.; Kuo S.-H.; Yeh K.-H.; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:11Z	Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis	Hsu C.; Shen Y.-C.; Cheng C.-C.; Hong R.-L.; Chang C.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:11Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-09-01T02:02:10Z	Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma	Cheng T.-Y.; Lin J.-T.; Chen L.-T.; Shun C.-T.; Wang H.-P.; Lin M.-T.; Wang T.-E.; ANN-LII CHENG; Wu M.-S.
臺大學術典藏	2021-09-01T02:02:10Z	An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer	Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; Yeh K.H.; Kao W.Y.; Chen L.T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:10Z	Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms	Lien H.-C.; Lu Y.-S.; ANN-LII CHENG; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; Huang C.-S.; Chang K.-J.; Yao Y.-T.
臺大學術典藏	2021-09-01T02:02:09Z	Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer	Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; Yeh K.-H.; Yang C.-H.; Lin J.-T.; ANN-LII CHENG; Lee Y.-C.
臺大學術典藏	2021-09-01T02:02:09Z	Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity	Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; Kuo S.-H.; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:09Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-09-01T02:02:08Z	Clinical studies with curcumin	Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:08Z	Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma	Lu Y.-S.; Kashida Y.; Kulp S.K.; Wang Y.-C.; Wang D.; Hung J.-H.; Tang M.; Lin Z.-Z.; Chen T.-J.; ANN-LII CHENG; Chen C.-S.
臺大學術典藏	2021-09-01T02:02:08Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Lin C.-C.; ANN-LII CHENG; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2021-09-01T02:02:07Z	Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells	Chia H.C.; Chen P.-J.; Lee P.-H.; ANN-LII CHENG; Hsu H.-C.; Cheng J.C.-H.
臺大學術典藏	2021-09-01T02:02:07Z	Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial	Lin C.-C.; Hsu C.; Hsu C.-H.; Hsu W.-L.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏	2021-09-01T02:02:07Z	Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression	Kuo S.-H.; Chen L.-T.; Wu M.-S.; Kuo K.-T.; Yeh K.-H.; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; Lin C.-W.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:06Z	A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma	Chen Y.-M.; Yu C.-J.; Yang C.-H.; Perng R.-P.; Tsai C.-M.; Shih J.-F.; ANN-LII CHENG; Lefresne F.; Barbier M.; Pouget J.-C.; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:06Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:33Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:32Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-09-01T01:54:32Z	Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial	Lin C.-C.; Hsu C.-H.; Hour T.-C.; ANN-LII CHENG; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:32Z	Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL	Lay J.-D.; Hong C.-C.; Huang J.-S.; Yang Y.-Y.; Pao C.-Y.; Liu C.-H.; Lai Y.-P.; Lai G.-M.; ANN-LII CHENG; Su I.-J.; Chuang S.-E.
臺大學術典藏	2021-09-01T01:54:31Z	Organization-based performance measures of cancer care quality: Core measure development for breast cancer in Taiwan	Chung K.-P.; Lai M.-S.; Cheng S.H.; Tang S.-T.; Huang C.C.; ANN-LII CHENG; Hsieh P.-C.
臺大學術典藏	2021-09-01T01:54:31Z	Molecular targeted therapy for advanced hepatocellular carcinoma	Shen Y.C.; Hsu C.; ANN-LII CHENG

显示项目 176-200 / 690 (共28页)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51169483 在线人数 : 640 教育部委托研究计画计画执行:国立台湾大学图书馆